GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The following is a reconciliation of goodwill by segment.

(in millions)	Medical Products and Therapies		Healthcare Systems and Technologies		Pharmaceuticals		Kidney Care		Total
Balance as of December 31, 2023	$	1,241	$	3,989	$	563	$	721	$	6,514
Currency translation	(38)		(7)		(17)		(22)		(84)
Balance as of March 31, 2024	$	1,203	$	3,982	$	546	$	699	$	6,430

Other Intangible Assets, Net

The following is a summary of our other intangible assets.

									Indefinite-lived intangible assets
(in millions)	Customer relationships		Developed technology, including patents		Trade names		Other amortized intangible assets		Trade names		In process Research and Development		Total
March 31, 2024
Gross other intangible assets	$	3,444	$	3,807	$	1,097	$	118	$	680	$	157	$	9,303
Accumulated amortization	(745)		(2,366)		(188)		(99)		—		—		(3,398)
Other intangible assets, net	$	2,699	$	1,441	$	909	$	19	$	680	$	157	$	5,905
December 31, 2023
Gross other intangible assets	$	3,446	$	3,823	$	1,106	$	120	$	680	$	157	$	9,332
Accumulated amortization	(689)		(2,285)		(180)		(99)		—		—		(3,253)
Other intangible assets, net	$	2,757	$	1,538	$	926	$	21	$	680	$	157	$	6,079